Sexual Dysfunction in Hypertensive Women
Several studies describe the existence of an association between sexual dysfunction and high blood pressure (hypertension), most often characterized by a decrease in the number of orgasms and the existence of dyspareunia. Hypertension is a contributing factor, and nonadherence to medication could amplify it. There are several ways to assess adherence to treatment: the use of declarative questionnaires, a method not without criticism because it is subject to the subjectivity of the declaration by the patient; and…
Conditions studied
Hypertension
About this study
Several studies describe the existence of an association between sexual dysfunction and high blood pressure (hypertension), most often characterized by a decrease in the number of orgasms and the existence of dyspareunia. Hypertension is a contributing factor, and nonadherence to medication could amplify it. There are several ways to assess adherence to treatment: the use of declarative questionnaires, a method not without criticism because it is subject to the subjectivity of the declaration by the patient; and drug dosages, a standard technique, although insufficiently disseminated due to the high cost and greater weight of the survey protocols. Drug non-compliance is multifactorial. In addition, it has been shown that having undesirable drug effects and / or being afraid of developing them is one of the major causes of non-compliance with antihypertensive treatments. The investigators hypothesize that DS is significantly more common among hypertensive women treated with non-observers compared to hypertensive women treated with observers. The main objective is to compare the prevalence of sexual dysfunction between a group of hypertensive women treated as observers and a group of hypertensive women treated as non-observers.
Interventions
- Biological: Blood sample for the determination of antihypertensives or their metabolites. — 15 ml of Blood sample for the determination of antihypertensives or their metabolites
- Behavioral: Questionnaire on sexual activity — Questionnaire on sexual activity in women
- Behavioral: Scale on hospital anxiety and depression — Scale on hospital anxiety and depression to detect anxious and depressive symptoms (14 questions)
- Behavioral: Morisky Questionaire — anti-hypertensive medication compliance questionnaire
Primary outcomes
- Analyse of sexual dysfunction (25 months)
Eligibility information
Study locations
- LAZARO Delphine, Toulouse, CHU de Toulouse 31059 France
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-05.